Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
| Record | Firm | Date |
|---|---|---|
| Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML (NCT03250338) | Arog Pharmaceuticals, Inc. | 2018-08-16 |
Track Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations automatically
Every clearance here is in the API, with alerts when new ones post.